IFN-γ and IP-10 in tracheal aspirates from premature infants: Relationship with bronchopulmonary dysplasia

Pediatric Pulmonology

Volumn 48, Issue 1, 2013, Pages 8-13

  Aghai, Zubair H ^a,b,d   Saslow, Judy G ^a,b   Mody, Kartik ^a   Eydelman, Riva ^a   Bhat, Vishwanath ^a,b   Stahl, Gary ^a,b   Pyon, Kee ^a   Bhandari, Vineet ^c  

^a UMDNJ Robert Wood Johnson Medical School at Camden   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

BPD; interferon gamma; lung; neonate

Indexed keywords

EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CHILD DEATH; CHILD HOSPITALIZATION; CONTROLLED STUDY; DILUTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPSIS; TRACHEAL ASPIRATION PROCEDURE;

EID: 84872834634     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22540     Document Type: Article

References (37)

1. Baraldi E, Filippone M,. Chronic lung disease after premature birth. N Engl J Med 2007; 357: 1946-1955.
2. Bhandari A, Bhandari V,. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci 2003; 8: e370-e380.
3. Bhandari A, Bhandari V,. Bronchopulmonary dysplasia: an update. Indian J Pediatr 2007; 74: 73-77.
4. Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, Ment LR, Gruen JR,. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006; 117: 1901-1906.
5. Bhandari A, Bhandari V,. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009; 123: 1562-1573.
6. Bhandari V,. Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med 2010; 15: 223-229.
7. Thomson A, Bhandari V,. Pulmonary biomarkers of bronchopulmonary dysplasia. Biomarker Insights 2008; 3: 361-373.
8. Harijith A, Choo-Wing R, Cataltepe S, Yasumatsu R, Aghai ZH, Janer J, Andersson S, Homer RJ, Bhandari V,. A role for matrix metalloproteinase 9 in IFNgamma-mediated injury in developing lungs: relevance to bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 2011; 44: 621-630.
9. Johnston CJ, Wright TW, Reed CK, Finkelstein JN,. Comparison of adult and newborn pulmonary cytokine mRNA expression after hyperoxia. Exp Lung Res 1997; 23: 537-552.
10. D'Angio CT, Johnston CJ, Wright TW, Reed CK, Finkelstein JN,. Chemokine mRNA alterations in newborn and adult mouse lung during acute hyperoxia. Exp Lung Res 1998; 24: 685-702.
11. Kallapur SG, Willet KE, Jobe AH, Ikegami M, Bachurski CJ,. Intra-amniotic endotoxin: chorioamnionitis precedes lung maturation in preterm lambs. Am J Physiol Lung Cell Mol Physiol 2001; 280: L527-L536.
12. Viscardi RM, Atamas SP, Luzina IG, Hasday JD, He JR, Sime PJ, Coalson JJ, Yoder BA,. Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res 2006; 60: 141-146.
13. An H, Nishimaki S, Ohyama M, Haruki A, Naruto T, Kobayashi N, Sugai T, Kobayashi Y, Mori M, Seki K, et al. Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-I in the cord blood as predictors of chronic lung disease in premature infants. Am J Obstet Gynecol 2004; 191: 1649-1654.
14. Ambalavanan N, Carlo WA, D'Angio CT, McDonald SA, Das A, Schendel D, Thorsen P, Higgins RD,. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009; 123: 1132-1141.
15. Bokodi G, Derzbach L, Banyasz I, Tulassay T, Vasarhelyi B,. Association of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates. Arch Dis Child Fetal Neonatal Ed 2007; 92: F25-F29.
16. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV,. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000; 61: 863-866.
17. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV,. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999; 26: 1-3.
18. Bose CL, Dammann CE, Laughon MM,. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008; 93: F455-F461.
19. Aghai ZH, Faqiri S, Saslow JG, Nakhla T, Farhath S, Kumar A, Eydelman R, Strande L, Stahl G, Leone P, et al. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone. J Perinatol 2008; 28: 149-155.
20. Bland RD, Xu L, Ertsey R, Rabinovitch M, Albertine KH, Wynn KA, Kumar VH, Ryan RM, Swartz DD, Csiszar K, et al. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1370-L1384.
21. Hirakawa H, Pierce RA, Bingol-Karakoc G, Karaaslan C, Weng M, Shi GP, Saad A, Weber E, Mariani TJ, Starcher B, et al. Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury. Am J Respir Crit Care Med 2007; 176: 778-785.
22. Padela S, Cabacungan J, Shek S, Belcastro R, Yi M, Jankov RP, Tanswell AK,. Hepatocyte growth factor is required for alveologenesis in the neonatal rat. Am J Respir Crit Care Med 2005; 172: 907-914.
23. Frank L,. Protective effect of keratinocyte growth factor against lung abnormalities associated with hyperoxia in prematurely born rats. Biol Neonate 2003; 83: 263-272.
24. Bry K, Whitsett JA, Lappalainen U,. IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol 2007; 36: 32-42.
25. Choo-Wing R, Nedrelow JH, Homer RJ, Elias JA, Bhandari V,. Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 2007; 293: L142-L150.
26. Vozzelli MA, Mason SN, Whorton MH, Auten RL Jr., Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. Am J Physiol Lung Cell Mol Physiol 2004; 286: L488-L493.
27. Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG, Elias JA,. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia ? Am J Respir Cell Mol Biol 2004; 31: 650-656.
28. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005; 112: 2477-2486.
29. Subramaniam M, Bausch C, Twomey A, Andreeva S, Yoder BA, Chang L, Crapo JD, Pierce RA, Cuttitta F, Sunday ME,. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2007; 176: 902-912.
30. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006; 12: 1286-1293.
31. De Luca A, Rindi L, Celi A, Melosini L, Paggiaro P, Ceccherini Nelli, Garzelli L, Freer G,. Intracellular detection of interleukin 17 and other cytokines in human bronchoalveolar lavage fluid: a first assessment. Immunol Lett 2012; 141: 204-209.
32. Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA,. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 1993; 147: 291-295.
33. Aghai ZH, Kumar S, Farhath S, Kumar MA, Saslow J, Nakhla T, Eydelman R, Strande L, Stahl G, Hewitt C, et al. Dexamethasone suppresses expression of nuclear factor-kappaB in the cells of tracheobronchial lavage fluid in premature neonates with respiratory distress. Pediatr Res 2006; 59: 811-815.
34. Fenton MJ, Vermeulen MW, Kim S, Burdick M, Strieter RM, Kornfeld H,. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun 1997; 65: 5149-5156.
35. Sharma M, Sharma S, Roy S, Varma S, Bose M,. Pulmonary epithelial cells are a source of interferon-gamma in response to Mycobacterium tuberculosis infection. Immunol Cell Biol 2007; 85: 229-237.
36. Jupelli M, Guentzel MN, Meier PA, Zhong G, Murthy AK, Arulanandam BP,. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice. J Immunol 2008; 180: 4148-4155.
37. Bhandari A, Panitch HB,. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 219-226.